Kirby mcinerney llp is investigating potential shareholder claims against regeneron pharmaceuticals, inc. (regn)

New york--(business wire)---- $regn #investigation--the law firm of kirby mcinerney llp reminds investors that the firm is investigating potential claims against regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn). the firm's ongoing investigation concerns whether regeneron and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [click here to learn more about the investigation] on april 10, 2024, the u.s. department of just.
REGN Ratings Summary
REGN Quant Ranking